Womens Health Flashcards
Pre-eclampsia
- hypertensive syndrome >20 weeks
RF fam hx prev preg pre-eclampsia/HELLP nulliparity BMI >30 age >40 multiple (twin) pregnancy diabetes PCOS autoimmune disease pre-existing htn CKD
Sx
hypertension after 20 weeks (>140/90)
proteinuria
headache, blurry vision, abdo pain, peripheral edema
Inv proteinuria fbc e/lfts fetal ultrasound
Pre-eclampsia Mx
Mx
low dose aspirin (100mg nocte) from 12 weeks
hospital admission and monitoring
labetalol 100mg bd. {methyldopa associated with depression}
seizure prevention
fluid restriction
early delivery (corticosteroid injection to mature baby lungs and organs)
HELLP (subtype of severe pre-eclampsia)
RF Sx H (haemolysis) EL (elevated liver enzymes) LP (low platelets)
HELLP Mx
Mx
Low dose aspirin (100mg nocte) from 12 weeks.
hospital admission and monitoring
early delivery
Placenta Previa
Placenta Abrupta
Placenta Accreta
Vasa Previa
Placenta Previa - placenta located close to os (lscs)
Placenta Abrupta - placenta ruptured from uterus
Placenta Accreta - placenta attached to muscle/bladder
Vasa Previa - fetal vessels unprotected or at os (lscs)
Early pregnancy bleeding
RF
20-40% pregnancies have 1st trimester bleeding
Ddx threatened miscarriage ectopic pregnancy endometrial implantation bleed (early weeks) trophoblastic disease (raised hCG)
Sx
Inv
bhcg serial every 48-72 hrs
u/s obstetric - rule out ectopic. review in a week
Early pregnancy bleeding mx
Mx
bhcg serial 48-72hrs apart
u/s obstetric
Miscarriage - Threatened Inevitable Incomplete Missed Complete Septic Recurrent
Threatened - PV bleed <20 weeks gestation
Inevitable - passage of POC of nonviable IUP occurring or about to occurr
Incomplete - retention of POC of non-viable IUP
Missed - no PV bleed. u/s diagnosis of non-viable IUP
Complete - full expulsion of POC of an IUP
Septic - miscarriage complicated by infection
Recurrent - 3+ consecutive miscarraiges
POC - products of conception
IUP - intrauterine pregnancy
Miscarriage Mx
Mx
expectant - wait and watch
- 60% incomplete miscarriage will complete in 2 weeks
- 90% complete in 6-8 weeks
- missed miscarriages take longer to expel
medicinal - misoprostol (prostaglandin) given (refer)
surgical - D&C
- for haemorrhage - for sepsis - risk anaesthetic, perforation, endometritis
RhD immunoglobulin for RhD negative women (ideally within 72 hours of sensitising event)
Follow up complications if pv bleeding, pv offensive discharge, lower pelvic pain for longer than 2 weeks -
retained products of conception
endometritis
Molar pregnancy (gestational trophoblastic disease)
- pregnancy related tumours
- hydatidiform moles are chromosomally abnormal
RF
prior molar pregnancy
extremes of age
Sx
PV bleed (early pregnancy)
unusually large uterus for gestational age
Inv
bHcg elevated
u/s obstetric
Molar pregnancy Mx
Mx
potential to become malignant
refer specialist
D&C +/- hysterectomy
Breast cancer
RF fam hx - red book long oestrogen exposure - early menarche, exogenous overweight inc age
Sx lumps, swelling breasts or armpits nipple change nipple discharge Peau d' orange, dimpling skin changes rash
Mod risk -
- one first-degree relative <50y or
- two first-degree relatives, same side or
- two second-degree relatives, same side, one <50y
Inv
Breast screening, 50-74y, every 2 years
- 40+, yearly, if first-degree relative <50y
Breast cancer Mx
Mx
FNA or core biopsy
Refer breast surgeon
Surgical, chemo, radiation, endocrine treatment
Types - DCIS (ductal carcinoma in situ) - non-invasive LCIS (lobular carcinoma in situ) - non-invasive Invasive ductal carcinoma Invasive lobular carcinoma Inflammatory breast cancer Phyllodes tumour of the breast Paget's disease of the nipple Locally advanced breast cancer Metastatic breast cancer
Subtypes -
Hormone receptor positive - ER+ (oestrogen receptor)
- PR+ (progesterone receptor)
HER2 positive (human epidermal growth factor receptor)
Triple negative breast cancer
Medication (endocrine treatment) -
Tamoxifen - for ER+ / PR+ (for pre and post menopausal women), 5-10yr course
Aromatase inhibitor - for ER+ (for postmenopausal women), 5-10yr course. Monitor bmd
Herceptin (trastuzumab) monoclonal antibody - for HER2+. 1 yr course
Colorectal cancer
RF
fam hx - red book
Mod risk -
- one first-degree relative <55y or
- two first-degree relative, same side or
- one first-degree and one second-degree relative, same side
Inv
FOBT 50-75y, every 2 years
if mod risk, colonoscopy 50+, every 5 years
if mod risk, colonoscopy from age (10 years prior to earliest age diagnosed crc in family), every 5 years
Colorectal cancer Mx
Mx
Refer GI for colonoscopy
Surgical